Allergan Limited Released Under Teva Settlement Terms
Trusted by teams at
Description
Allergan Limited is listed as a released entity in the New Hampshire opioid litigation settlement with Teva. The agreement includes broad releases and a long-term abatement structure.
Contract Details
Vendor
ALLERGAN LIMITED
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Covered by Teva Global Opioid Settlement Agreement (as an affiliate), relief as described
Renewal Date
2036-07-15
Renewal Info
Obligations and release align with the 13-year Teva settlement period, with no traditional renewal beyond set term.
More from ALLERGAN LIMITED
Issuing Agency
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.